FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Advanced Urologic Cancer Consensus Conference (AUC3) 2025 - ACS Journals
Gevorg Tamamyan: We Can Do More…
Meet the 2025 BCRF-AACR Career Development Award Recipients - AACR
Arnaud Lallouette: Energy, Ambition, and Teamwork Across the Servier Performance Summit 2025 Tour
Richard R. Barakat: A Powerful Northwell Cancer Institute–START Collaboration Bringing Early-Phase Trials to Patients
Clifford Hudis Encourages ASCO Members to Participate in the 2025 Survey as It Nears Close
Senator Ron Johnson Thanks Secretary Kennedy for Advocacy in Early Sscreening for Rare Diseases
